Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Repligen receives Phase II SBIR grant for angiogenesis research

April 21, 1998

New water-soluble dolastatin derivatives with potent antitumor activity

April 21, 1998

Phase I data reported for antitumor bisnaphthalimide DMP-840

April 21, 1998

Tricyclic compounds inhibiting protein farnesyltransferase claimed by Schering-Plough

April 21, 1998

mRNA splicing appears to trigger metastasis in prostate cancer

April 21, 1998

RPR's Gliadel Wafer approved in Argentina

April 20, 1998

P&U claims new distamycin derivatives and their use as antitumor and antiviral agents

April 20, 1998

Synthetic dolastatin derivatives as antitumor agents

April 20, 1998

Idun seeks licensing partners for apoptosis regulators

April 20, 1998

SuperGen's Nipent granted orphan drug status

April 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Rethinking anorexia: A disorder of mind and metabolism
BioWorld Science
Anorexia nervosa (AN) is a complex and severe eating disorder that has long been considered a psychiatric condition driven by distorted body image and maladaptive...